The vendor-agnostic system enables remote scanning in a command center configuration and real-time remote expertise.
RadNet subsidiary DeepHealth Inc has received US Food and Drug Administration (FDA) 510(k) clearance for TechLive, a remote scanning solution enabling centralized operation and supervision of MR, CT, PET/CT, and ultrasound procedures.
Amidst tech labor shortages and inflationary wage pressure, TechLive allows technologists to scan for multiple locations, which the company says enables improved operational efficiency, extends center operating hours, and enhances access to complex procedures. More than 300 of RadNet’s MR, CT, PET/CT, and ultrasound systems are now connected with DeepHealth’s TechLive solution.
In a pilot deployment at 64 locations inside of RadNet’s New York area facilities, TechLive contributed to a 42% decrease in MRI room closure hours during the second quarter of 2025 compared to the same period in 2024, according to a release from the company. Additionally, as a result of the remote expert involvement during the same pilot deployment, TechLive contributed to an increase in complex procedures.
Furthermore, in extending remote scanning capabilities to ultrasound, DeepHealth notes that TechLive is enabling experienced senior sonographers and physicians to remotely guide technologists on-site through complex cases in a modality that is heavily dependent upon real-time, operator expertise.
“TechLive represents a paradigm shift in how we approach imaging operations,” says Sham Sokka, PhD, chief operating and technology officer at DeepHealth, in a release. “By enabling real-time remote expertise, we are not only addressing today’s staffing challenges, we are creating a foundation for more efficient, financially sustainable, and high-quality patient care across the broadest set of imaging modalities. This FDA clearance validates DeepHealth’s vision of a connected imaging ecosystem that scales human expertise beyond physical boundaries.”
ID 25297416 © Andrei Malov | Dreamstime.com
